CHRISTINA MCKENNA-LEZZO: Open Payments
NPI 1083313845 · BRICK, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,408 in 68 payments from 15 companies in 2025. Trend: 2023 $560 · 2024 $2,797 · 2025 $1,408
Food & beverage: $1,324Education: $84
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 20 | $317 |
| Madrigal Pharmaceuticals | 17 | $251 |
| Ardelyx, Inc. | 6 | $198 |
| Gilead Sciences, Inc. | 1 | $122 |
| Janssen Biotech, Inc. | 2 | $104 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $89 |
| QOL Medical, LLC | 3 | $68 |
| GENZYME CORPORATION | 3 | $65 |
| Regeneron Healthcare Solutions, Inc. | 2 | $38 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $35 |
Products named: REZDIFFRA, RINVOQ, IBSRELA, Livdelzi, TREMFYA, DUPIXENT, ENTYVIO, Sucraid.
Industry payments across NJ — which companies pay providers there.
